City

Clinical trials near Kansas City, United States

Active studies with a listed research site in Kansas City, United States.

29active studies

21recruiting now

6countries represented

53largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 3

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Obesity, OverweightCondition

Maridebart Cafraglutide, PlaceboTreatment

Japan, Puerto Rico37 locations

AmgenSponsor

Updated 2026-09-03 · NCT07684144See eligibility →

Recruiting nowPhase 2

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

B-cell Acute Lymphoblastic Leukemia, ObesityCondition

IDEAL2 InterventionTreatment

United States16 locations

Etan OrgelSponsor

Updated 2026-08-19 · NCT05082519See eligibility →

Recruiting nowNot applicable

Cooking Skills to Improve Long-Term Weight Loss in Young Adults With Intellectual Disabilities

Intellectual Disability, Overweight and ObesityCondition

Weight Loss Plus Cooking, Traditional Weight LossTreatment

United States1 locations

University of Kansas Medical CenterSponsor

Updated 2026-08-11 · NCT06961591See eligibility →

Recruiting nowPhase 2

Phentermine's Impact on Treatment in Teens

Childhood ObesityCondition

Phentermine, PlaceboTreatment

United States6 locations

Russell McCulloh, MDSponsor

Updated 2026-08-10 · NCT07282340See eligibility →

Recruiting nowPhase 2

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

Breast Atypical Hyperplasia, Breast CarcinomaCondition

Biospecimen Collection, MammographyTreatment

United States3 locations

National Cancer Institute (NCI)Sponsor

Updated 2026-08-04 · NCT06195306See eligibility →

Recruiting nowNot applicable

Gestational Response, Outcomes, and Weight After GLP-1 Use

Pregnant Individuals, Obesity & OverweightCondition

Intervention not listedTreatment

United States1 locations

University of Kansas Medical CenterSponsor

Updated 2026-08-04 · NCT07743567See eligibility →

Recruiting nowPhase 2

Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity

Obesity, OverweightCondition

KAI-7535, PlaceboTreatment

Australia, United States36 locations

KaileraSponsor

Updated 2026-07-28 · NCT07497880See eligibility →

Recruiting nowNot applicable

Changes in Body Composition Including Muscle With Anti-Obesity Medications, Both With and Without Exercise

Obesity & OverweightCondition

Standard Medical Care with an Obesity Management Medication, Cardiovascular Exercise TrainingTreatment

United States1 locations

University of Kansas Medical CenterSponsor

Updated 2026-07-15 · NCT07698145See eligibility →

Recruiting nowNot applicable

Feasibility and Plausible Effectiveness of a Lifestyle Intervention in Kidney Transplant Recipients (HEAL)

Kidney Transplant, Overweight or Obese AdultsCondition

Standard medical care, Monitoring ContactsTreatment

United States1 locations

University of Kansas Medical CenterSponsor

Updated 2026-07-02 · NCT06640179See eligibility →

Recruiting nowPhase 2

A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight

Overweight or Obesity and Elevated Liver FatCondition

Maridebart cafraglutide, PlaceboTreatment

United States23 locations

AmgenSponsor

Updated 2026-06-18 · NCT07441252See eligibility →

Recruiting nowPhase 2

A Phase 2 Study to Evaluate the Pharmacodynamics, Safety and Tolerability of BGE-102 in Participants With Obesity and Cardiovascular Risk Factors

Obesity and Cardiovascular RiskCondition

Oral BGE-102, Oral Placebo Matching BGE-102Treatment

Puerto Rico, United States13 locations

BioAge Labs, Inc.Sponsor

Updated 2026-06-18 · NCT07656727See eligibility →

Recruiting nowPhase 1

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity

ObesityCondition

MBX 4291, PlaceboTreatment

United States4 locations

MBX BiosciencesSponsor

Updated 2026-06-09 · NCT07142707See eligibility →

Recruiting nowNot applicable

Muscle and Movement With Anti-Obesity Medications

Obesity and OverweightCondition

Standard Medical Care (SMC), Monitoring ContactsTreatment

United States1 locations

University of Kansas Medical CenterSponsor

Updated 2026-05-11 · NCT06645470See eligibility →

Recruiting nowNot applicable

iAmHealthy Clinical Practice Guideline (CPG)

Pediatric Obesity, Rural HealthCondition

Participants: iAmHealthy, Participants: NewsletterTreatment

United States4 locations

University of Kansas Medical CenterSponsor

Updated 2026-04-13 · NCT06888011See eligibility →

Recruiting nowNot applicable

Brain Outcomes With Lifestyle Change in Down Syndrome

Down Syndrome, Alzheimer DiseaseCondition

Diet, Health EducationTreatment

United States1 locations

University of Kansas Medical CenterSponsor

Updated 2026-03-11 · NCT05985486See eligibility →

Recruiting nowNot applicable

Comparision of Aerobic Exercise to Aerobic Plus Yoga Exercise for Weight Loss in Adults With Overweight or Obesity.

Obesity and OverweightCondition

Diet, Aerobic ExerciseTreatment

United States1 locations

University of Kansas Medical CenterSponsor

Updated 2026-01-09 · NCT06636773See eligibility →

Recruiting nowPhase 1, Phase 2

Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

Hypertension, Cardiovascular DiseasesCondition

Ascorbic acid solution (American Regent Laboratories Inc.), SalineTreatment

United States1 locations

University of Kansas Medical CenterSponsor

Updated 2025-06-08 · NCT04715022See eligibility →

Recruiting nowPhase 1

Mitigating the Pro-inflammatory Phenotype of Obesity

Blood Pressure, DiabetesCondition

Hydrochlorothiazide 12.5Mg Tab, Clonidine PillTreatment

United States1 locations

University of Kansas Medical CenterSponsor

Updated 2025-06-05 · NCT04934228See eligibility →

Recruiting nowPhase 2

Social Determinants and a Diabetes Prevention Program Tailored for African Americans

PreDiabetes, Overweight and ObesityCondition

Culturally Tailored Diabetes Prevention Program, Culturally Tailored DPP Enhanced with Socioeconomic SupportsTreatment

United States2 locations

University of Missouri, Kansas CitySponsor

Updated 2025-05-25 · NCT05301413See eligibility →

Recruiting nowNot applicable

Transduction of Sympathetic Neural Activity in Human Obesity Without Hypertension

ObesityCondition

ascorbic acidTreatment

United States1 locations

University of Kansas Medical CenterSponsor

Updated 2024-10-03 · NCT06626113See eligibility →

Recruiting nowNot applicable

International Weight Control Registry

Weight Loss, OverweightCondition

Intervention not listedTreatment

United States7 locations

Tufts UniversitySponsor

Updated 2024-09-19 · NCT04907396See eligibility →

Active, not recruitingNot applicable

Addressing Social Determinants of Health in Child Obesity Treatment Using Community Health Workers

Child Obesity, Social Determinants of HealthCondition

Community Health Worker, Child weight management interventionTreatment

United States1 locations

Children's Mercy Hospital Kansas CitySponsor

Updated 2026-09-02 · NCT06520657See eligibility →

Active, not recruitingPhase 2

Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

Overweight, Type 2 DiabetesCondition

Petrelintide, PlaceboTreatment

United States48 locations

Zealand PharmaSponsor

Updated 2026-08-21 · NCT06926842See eligibility →

Active, not recruitingNot applicable

Weight Loss Management in Endometrial Cancer Survivors

Endometrial Cancer Survivors, Weight ManagementCondition

Weight loss with pharmacotherapy, Weight loss without pharmacotherapyTreatment

United States1 locations

University of Kansas Medical CenterSponsor

Updated 2026-08-12 · NCT06877572See eligibility →

Active, not recruitingNot applicable

iAmHealthy Parents First: A Televideo Parent and Child Obesity Program for Rural Families

Weight Loss, Pediatric ObesityCondition

iAmHealthy Parents First, iAmHealthyTreatment

United States1 locations

University of Kansas Medical CenterSponsor

Updated 2026-03-30 · NCT05612971See eligibility →

Active, not recruitingPhase 3

A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity

ObesityCondition

Retatrutide, PlaceboTreatment

Canada, United Kingdom53 locations

Eli Lilly and CompanySponsor

Updated 2026-03-03 · NCT06859268See eligibility →

Active, not recruitingPhase 2

Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist

Endocrinology, Diabetes, Type IICondition

AZD6234, Placebo to matchTreatment

United States18 locations

AstraZenecaSponsor

Updated 2026-03-03 · NCT06851858See eligibility →

Active, not recruitingNot applicable

Rural Engagement in TelemedTeam for Options in Obesity Treatment Solutions

Obesity, Obesity, MorbidCondition

Local Care + Model, Team Care ModelTreatment

United States1 locations

University of Kansas Medical CenterSponsor

Updated 2025-11-25 · NCT05710510See eligibility →

Active, not recruitingNot applicable

The AUDACITY Study (AllUrion Device in Adults With Clinical ObesITY)

ObesityCondition

AGBSTreatment

United States17 locations

Allurion TechnologiesSponsor

Updated 2024-10-26 · NCT05368259See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.

Clinical trials near Kansas City, United States

Current studies

Related cities